These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15912812)

  • 41. Characterisation of invasive meningococcal isolates from Italian children and adolescents.
    Mastrantonio P; Sofia T; Neri A; Fazio C; Stefanelli P
    Clin Microbiol Infect; 2007 Jan; 13(1):100-3. PubMed ID: 17184297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain).
    Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA;
    Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
    Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
    J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A neonate in septic shock.
    Onyejiaka NA; Ali NB; Fogarasi SR
    Clin Pediatr (Phila); 2010 Mar; 49(3):297-9. PubMed ID: 20164076
    [No Abstract]   [Full Text] [Related]  

  • 45. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Meningococcal infection. Clinical, therapeutic and nursing aspects].
    Lemberger C
    Kinderkrankenschwester; 2006 Aug; 25(8):318-21. PubMed ID: 16937826
    [No Abstract]   [Full Text] [Related]  

  • 48. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Epidemiology and clinic of meningococcal infections. Indications for immunization].
    Goetz O; Peller P
    MMW Munch Med Wochenschr; 1980 Oct; 122(41):1411-2. PubMed ID: 6780820
    [No Abstract]   [Full Text] [Related]  

  • 50. Meningococcal disease in Arkansas in 1995.
    J Ark Med Soc; 1996 May; 92(12):633-4. PubMed ID: 8936024
    [No Abstract]   [Full Text] [Related]  

  • 51. Cytokine activation in purulent pericarditis caused by Neisseria meningitidis serogroup C.
    de Souza AL; Marques Salgado M; Romano CC; Alkmin Md; Sztajnbok J; Vidal JE; Duarte AJ; Seguro AC
    Int J Cardiol; 2006 Nov; 113(3):419-21. PubMed ID: 16324757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meningococcal meningitis and meningococcal septicemia.
    Deorari AK; Verma IC; Paul VK
    Indian Pediatr; 1987 May; 24(5):444-5. PubMed ID: 3679497
    [No Abstract]   [Full Text] [Related]  

  • 53. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa.
    von Gottberg A; du Plessis M; Cohen C; Prentice E; Schrag S; de Gouveia L; Coulson G; de Jong G; Klugman K;
    Clin Infect Dis; 2008 Feb; 46(3):377-86. PubMed ID: 18181736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization strategies for the control of serogroup C meningococcal disease in developed countries.
    De Wals P
    Expert Rev Vaccines; 2006 Apr; 5(2):269-75. PubMed ID: 16608426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 56. Meningitis: ousting the organism.
    Robinson P
    Community Outlook; 1987 Jun; ():20-2. PubMed ID: 3649283
    [No Abstract]   [Full Text] [Related]  

  • 57. [Global spread of meningococcal serogroup W135].
    Vestergård D; David KP
    Ugeskr Laeger; 2008 Sep; 170(39):3044-7. PubMed ID: 18822228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.
    Traoré Y; Njanpop-Lafourcade BM; Adjogble KL; Lourd M; Yaro S; Nacro B; Drabo A; Parent du Châtelet I; Mueller JE; Taha MK; Borrow R; Nicolas P; Alonso JM; Gessner BD
    Clin Infect Dis; 2006 Oct; 43(7):817-22. PubMed ID: 16941360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.
    Backhouse JL; Gidding HF; MacIntyre CR; McIntyre PB; Gilbert GL
    Vaccine; 2007 Jan; 25(7):1310-5. PubMed ID: 17069937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
    Raghunathan PL; Jones JD; Tiendrebéogo SR; Sanou I; Sangaré L; Kouanda S; Dabal M; Lingani C; Elie CM; Johnson S; Ari M; Martinez J; Chatt J; Sidibe K; Schmink S; Mayer LW; Kondé MK; Djingarey MH; Popovic T; Plikaytis BD; Carlone GM; Rosenstein N; Soriano-Gabarró M
    J Infect Dis; 2006 Mar; 193(5):607-16. PubMed ID: 16453255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.